Industry

DUBLIN–(BUSINESS WIRE)–The “RNA Therapy Market Research Report by Technology (Enabled Technologies and Enabling Technologies), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global RNA Therapy Market size was estimated at USD 1,328.36 million … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Psoriasis Therapeutics Market Research Report by Molecule (Biologics and Small Molecules), Route of Administration, Dosage Forms, Mechanism of Action, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Psoriasis Therapeutics Market size was estimated … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Parenteral Nutrition Market Research Report by Nutrient Type (Amino Acids, Carbohydrates, and Electrolytes), Dosage Form, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Parenteral Nutrition Market size was estimated at USD 6,529.10 … [Read more…]

Company announces completion of Phase 1 dose escalation ahead of schedule for IO-108, a first-in-class antibody targeting LILRB2 (ILT4) Signals of clinical activity observed in multiple tumor types for IO-108 as a single agent and in combination with an anti-PD-1 PALO ALTO, Calif.–(BUSINESS WIRE)–#ILT3–Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage cancer immunotherapy company developing novel … [Read more…]

VIENNA, Va.–(BUSINESS WIRE)–$CVM #Multikine–CEL-SCI Corporation (NYSE American: CVM) announces that Geert Kersten, Chief Executive Officer, will be on Reddit AMA (“Ask Me Anything”) today at 12:30 PM ET to discuss Multikine and our recent publications at ASCO 2022. Come ask him anything relevant at reddit.com/r/IAmA/. About CEL-SCI Corporation CEL-SCI believes that boosting a patient’s immune … [Read more…]

ROCKVILLE, Md.–(BUSINESS WIRE)–Creative Bio-Peptides, Inc, a preclinical-stage biotechnology company developing novel therapies to balance the innate immune system and promote regeneration of damaged neurons, today announced the publication of findings from a preclinical study showing that treatment with the small oral peptide chemokine receptor antagonist RAP-103 reduced the amount of opioid needed after surgery by … [Read more…]

Data demonstrate favorable safety and efficacy profile for the duodenal jejunal bypass liner (DJBL) technology BOSTON–(BUSINESS WIRE)–GI Dynamics® Inc., a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce positive data from the Association of British Clinical Diabetologists (ABCD) Worldwide EndoBarrier Registry and data from … [Read more…]

Medallia expands its healthcare solution with the addition of CAHPS for MIPS survey administration to help organizations meet regulatory requirements and improve patient experience. PLEASANTON, Calif.–(BUSINESS WIRE)–Medallia, Inc., the global leader in customer and employee experience, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved Medallia as an authorized vendor to … [Read more…]

Eldredge brings a wide range of financial leadership experience across the healthcare and life sciences industries, including ThermoFisher, Syneos Health and Mass General Brigham BOSTON–(BUSINESS WIRE)–PathAI, a global leader in AI-powered pathology, today announced that it has appointed Brandon Eldredge as Chief Financial Officer. An experienced financial leader with a track record for delivering value … [Read more…]

Leverages next generation core platform to accelerate new product development that makes healthcare more affordable, predictable, and simple MORRISTOWN, N.J.–(BUSINESS WIRE)–Majesco, a global leader of cloud insurance software solutions for insurance business transformation, today announced that Cigna, a global health service company, is now using Majesco L&A and Group Core Suite on Majesco CloudInsurer® for … [Read more…]